Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC)

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 414-418

  Navarria, Pierina ^a   Ascolese, Anna Maria ^a   Mancosu, Pietro ^a   Alongi, Filippo ^a   Clerici, Elena ^a   Tozzi, Angelo ^a   Iftode, Cristina ^a   Reggiori, Giacomo ^a   Tomatis, Stefano ^a   Infante, Maurizio ^a   Alloisio, Marco ^a   Testori, Alberto ^a   Fogliata, Antonella ^b   Cozzi, Luca ^b   Morenghi, Emanuela ^a   Scorsetti, Marta ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

NSCLC; SBRT; Volumetric modulated Arc Therapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ORGANS AT RISK; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE REDUCTION; RADIATION INJURY; RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; VOLUMETRIC MODULATED ARC THERAPY;

NSCLC; SBRT; VOLUMETRIC MODULATED ARC THERAPY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84881477391     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.04.016     Document Type: Article

References (21)

1. S. Cykert, P. Dilworth-Anderson, and M.H. Monroe Factors associated with decisions to undergo surgery among patients with newly diagnosed early stage lung cancer JAMA 303 2010 2368 2376
2. N.P. Rowell, and C.J. Williams Radical radiotherapy for stage I/II non small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review Thorax 56 2001 628 638
3. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431
4. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
5. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
6. W.F. Verbakel, S. Senan, and J.P. Cuijpers Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs Radiother Oncol 93 2009 122 124
7. M.S. Hoogeman, J.J. Nuyttens, and P.C. Levendag Time dependence of intra-fraction patient motion assessed by repeat stereoscopic imaging Int J Radiat Oncol Biol Phys 70 2008 609 618
8. K. Otto Volumetric modulated arc therapy: IMRT in a single gantry arc Med Phys 35 2008 310 317
9. W.F. Verbakel, J.P. Cuijpers, and D. Hoffmans Volumetric intensity-modulated arc therapy vs. conventional IMRT in head and- neck cancer: a comparative planning and dosimetric study Int J Radiat Oncol Biol Phys 74 2009 252 259
10. I.T. Kuijper, M. Dahele, and S. Senan Volumetric modulated arc therapy versus conventional intensity modulated radiation therapy for stereotactic spine radiotherapy: a planning study and early clinical data Radiother Oncol 94 2010 224 228
11. G. Kragl, S. Wetterstedt, and B. Knausl Dosimetric characteristics of 6 and 10 MV unflattened photon beams Radiother Oncol 93 2009 141 146
12. National Cancer Institute. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, Version 3.0. DCTD, NCI, NIH, NHHS. March 31, 2003. Available from http://cteo.cancer.gov.
13. S. Bral, T. Gevaert, and N. Linthout Prospective, risk-adapted strategy of stereotactic body radiotherapy for early stage non small cell lung cancer: results of a phase II trial Int J Radiat Oncol Biol Phys 80 2011 1343 1349
14. M. Scorsetti, M. Bignardi, and A. Clivio Volumetric modulated arc radiotherapy compared with static Gantry intensity-modulated radiotherapy for malignant pleural mesotelioma tumor: a feasibility study Int J Radiat Oncol Biol Phys 77 2010 924 929
15. P. Navarria, P. Mancosu, and F. Alongi Vertebral metastases reirradiation with volumetric modulated arc therapy Radiother Oncol 102 2012 416 420
16. A. Holt, C. van Vliet-Vroegindeweij, and A. Mans Volumetric modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques Int J Radiat Oncol Biol Phys 81 2011 1560 1567
17. C.L. Ong, W.F. Verbakel, and J.P. Cuijpers Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques Radiother Oncol 97 2010 437 442
18. M. Scorsetti, F. Alongi, and S. Castiglioni Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments Radiat Oncol 6 2011 113
19. F. Alongi, A. Fogliata, and E. Clerici Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients Radiat Oncol 7 2012 204
20. I. Lohse, S. Lang, and J. Hrbacek Effect of high dose per pulse flattening filter free beams on cancer cell survival Radiother Oncol 101 2011 226 232
21. B.S. Sørensen, A. Vestergaard, and J. Overgaard Dependence of cell survival on instantaneous dose rate of a linear accelerator Radiother Oncol 101 2011 223 225